From Biotech to Blockchain: Cypherpunk’s High-Conviction Pivot

[encrypted]

Formerly known as Leap Therapeutics, Cypherpunk Technologies completed a full rebrand in late 2025, transforming from a biotech firm into a Zcash-focused digital asset company. Since then, its stock price has surged nearly 170%, reflecting investor enthusiasm for the company’s sharply defined crypto strategy.

Backing from Winklevoss Capital has added further credibility, positioning Cypherpunk as one of the more aggressive public-market adopters of single-asset crypto treasury strategies. Unlike diversified Bitcoin plays, this approach concentrates risk — and upside — around one narrative: privacy.

[chainsniff]

170% off a rebrand + narrative shift is peak 2025 markets tbh